Gelofusine reduces renal uptake of RAFT-RGD. Gelofusine reduced renal uptake of RAFT-RGD, a tetrameric RGD-based peptide that specifically targets the integrin αvβ3, without affecting its local distribution
Cancer Science (Impact Factor: 3.53). 06/2012; 103(6):Junecover. DOI: 10.1111/j.1349-7006.2012.02278.x
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.